Announcements
- Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
- Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
- Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
- Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
- Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
- Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
- Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
- Vericel to Present at the Stephens Annual Investment Conference
- Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
More ▼
Key statistics
On Wednesday, Vericel Corp (ATQP:DEU) closed at 43.00, -11.89% below its 52-week high of 48.80, set on Apr 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 43.20 |
---|---|
High | 44.20 |
Low | 43.00 |
Bid | 43.00 |
Offer | 43.20 |
Previous close | 43.40 |
Average volume | 68.89 |
---|---|
Shares outstanding | 48.38m |
Free float | 47.97m |
P/E (TTM) | -- |
Market cap | 2.23bn USD |
EPS (TTM) | -0.0684 USD |
Data delayed at least 15 minutes, as of Apr 24 2024.
More ▼